Literature DB >> 11092398

Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand.

J Xu1, J W Tan, L Huang, X H Gao, R Laird, D Liu, S Wysocki, M H Zheng.   

Abstract

A complementary DNA (cDNA) encoding the rat homologue of receptor activator of NF-kappaB ligand/osteoprotegerin ligand/osteoclast differentiation factor/tumor necrosis factor (TNF)-related activation-induced cytokine (RANKL/OPGL/ODF/TRANCE) was cloned and sequenced from tibias of ovariectomized (OVX) rats. The predicted amino acid sequence of rat RANKL (rRANKL) has 84% and 96% identity to that of human and mouse RANKL, respectively, and 35% and 37% similarity to that of human and mouse TNF-related apoptosis-inducing ligand (TRAIL), respectively. RANKL transcripts were expressed abundantly in the thymus and bone tissues of OVX rats. rRANKL has a single hydrophobic region between residues 53 and 69, which is most likely to serve as a transmembrane domain. The long C-terminal region containing beta-sheet-forming sequences of the TNF-like core is considered the extracellular region. Three truncated domains within the TNF-like core region were expressed as glutathione S-transferase (GST) fusion proteins and investigated for their ability to induce osteoclastogenesis. The results showed that GST-rRANKL (aa160-318) containing the full TNF-like core region had the highest capability to induce the formation of osteoclast-like cells from RAW264.7 cells. GST-rRANKL (aa239-318 and aa160-268) had lesser degrees of osteoclast inductivity. Furthermore, the GST-rRANKL (aa160-318) is capable of (1) inducing osteoclast formation from rat spleen cells in the presence of macrophage colony-stimulating factor (M-CSF), (2) stimulating mature rat osteoclast polarization and bone resorption ex vivo, and (3) inducing systemic hypercalcemia in vivo; thus the full TNF-like core region of rRANKL is an important regulator of calcium homeostasis and osteoclastic function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092398     DOI: 10.1359/jbmr.2000.15.11.2178

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  46 in total

1.  Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption.

Authors:  Nathan J Pavlos; Jiake Xu; Dietmar Riedel; Joyce S G Yeoh; Steven L Teitelbaum; John M Papadimitriou; Reinhard Jahn; F Patrick Ross; Ming H Zheng
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

2.  Cytoplasmic terminus of vacuolar type proton pump accessory subunit Ac45 is required for proper interaction with V(0) domain subunits and efficient osteoclastic bone resorption.

Authors:  Haotian Feng; Taksum Cheng; Nathan J Pavlos; Kirk H M Yip; Amerigo Carrello; Ruth Seeber; Karin Eidne; Ming H Zheng; Jiake Xu
Journal:  J Biol Chem       Date:  2008-01-28       Impact factor: 5.157

3.  p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.

Authors:  Kirk H M Yip; Haotian Feng; Nathan J Pavlos; Ming H Zheng; Jiake Xu
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase.

Authors:  Shek Man Chim; An Qin; Jennifer Tickner; Nathan Pavlos; Tamara Davey; Hao Wang; Yajun Guo; Ming Hao Zheng; Jiake Xu
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

5.  Upregulation of receptor activator of nuclear factor-kappaB ligand expression in the thymic subcapsular, paraseptal, perivascular, and medullary epithelial cells during thymus regeneration.

Authors:  Hee-Woo Lee; Bong-Seon Kim; Hyung-Jin Kim; Choong-Won Lee; Hyun-Jung Yoo; Jae-Bong Kim; Sik Yoon
Journal:  Histochem Cell Biol       Date:  2005-04-21       Impact factor: 4.304

6.  Tctex-1, a novel interaction partner of Rab3D, is required for osteoclastic bone resorption.

Authors:  Nathan J Pavlos; Tak Sum Cheng; An Qin; Pei Ying Ng; Hao-Tian Feng; Estabelle S M Ang; Amerigo Carrello; Ching-Hwa Sung; Reinhard Jahn; Ming-Hao Zheng; Jiake Xu
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

Review 7.  Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target.

Authors:  Tzu-hua Lin; Yasunobu Tamaki; Jukka Pajarinen; Heather A Waters; Deanna K Woo; Zhenyu Yao; Stuart B Goodman
Journal:  Acta Biomater       Date:  2013-10-01       Impact factor: 8.947

8.  Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.

Authors:  Kazunori Hamamura; Nancy Tanjung; Hiroki Yokota
Journal:  J Bone Miner Metab       Date:  2013-03-28       Impact factor: 2.626

9.  Retinoic acid increases proliferation of human osteoclast progenitors and inhibits RANKL-stimulated osteoclast differentiation by suppressing RANK.

Authors:  Lijuan Hu; Thomas Lind; Anders Sundqvist; Annica Jacobson; Håkan Melhus
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

10.  Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.

Authors:  HaoTian Feng; Taksum Cheng; James H Steer; David A Joyce; Nathan J Pavlos; Chengloon Leong; Jasreen Kular; Jianzhong Liu; Xu Feng; Ming H Zheng; Jiake Xu
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.